These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 12676875

  • 41. Comparison of four molecular typing methods for evaluating genetic diversity among Candida albicans isolates from human immunodeficiency virus-positive patients with oral candidiasis.
    Díaz-Guerra TM, Martínez-Suárez JV, Laguna F, Rodríguez-Tudela JL.
    J Clin Microbiol; 1997 Apr; 35(4):856-61. PubMed ID: 9157142
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Genotyping Candida albicans from Candida leukoplakia and non-Candida leukoplakia shows no enrichment of multilocus sequence typing clades but enrichment of ABC genotype C in Candida leukoplakia.
    Abdulrahim MH, McManus BA, Flint SR, Coleman DC.
    PLoS One; 2013 Apr; 8(9):e73738. PubMed ID: 24058485
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Virulence attributes and genetic variability of oral Candida albicans and Candida tropicalis isolates.
    da Costa KR, Ferreira JC, Lavrador MA, Baruffi MD, Candido RC.
    Mycoses; 2012 May; 55(3):e97-e105. PubMed ID: 22035510
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients.
    Woldeamanuel Y, Abate D.
    Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
    Martínez M, López-Ribot JL, Kirkpatrick WR, Bachmann SP, Perea S, Ruesga MT, Patterson TF.
    J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
    [Abstract] [Full Text] [Related]

  • 52. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.
    Dromer F, Improvisi L, Dupont B, Eliaszewicz M, Pialoux G, Fournier S, Feuillie V.
    AIDS; 1997 Jul 15; 11(9):1095-101. PubMed ID: 9233455
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
    Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH.
    J Mycol Med; 2016 Mar 15; 26(1):35-41. PubMed ID: 26627124
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.
    AIDS; 1994 Jul 15; 8(7):945-50. PubMed ID: 7946104
    [Abstract] [Full Text] [Related]

  • 59. Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique.
    Lischewski A, Harmsen D, Wilms K, Baier G, Gunzer U, Klinker H, Wilhelm M, Schwinn A, Hacker J.
    Mycoses; 1999 Jul 15; 42(5-6):371-83. PubMed ID: 10536429
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.